Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02439645 · ClinicalTrials.gov registry record
A Registry to Determine the Clinical and Genetic Risk Factors for Torsade De Pointes
A clinical trial, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- 11
- Enrollment target
NCT02439645: Clinical Trial study, sponsored by Massachusetts General Hospital.
NCT02439645 is a clinical trial that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02439645 was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- 11 participants
- Enrollment target
Study Summary
This is a registry to examine genetic and clinical predictors of torsade de pointes events.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2013-10 |
| Est. Completion | 2019-07-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02439645
The ClinicalTrials.gov registry entry for NCT02439645 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02439645 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02439645 about?
NCT02439645 is a clinical study titled "A Registry to Determine the Clinical and Genetic Risk Factors for Torsade De Pointes". This is a registry to examine genetic and clinical predictors of torsade de pointes events.
What is the current status of trial NCT02439645?
This trial is currently terminated. The enrollment target is 11 participants. The study started on 2013-10. Estimated completion is 2019-07-26.
Who is sponsoring clinical trial NCT02439645?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.